Wegovy and Sleep: Does Semaglutide Change How You Rest?

Does Wegovy help you sleep better?

For people whose poor sleep stems from their weight, Wegovy can make a real difference over time. Obstructive sleep apnoea (where the airway partially closes during sleep, causing repeated shallow breathing and fragmented rest) is strongly associated with excess weight. As body weight falls on semaglutide, the physical pressure on the airway reduces, and several people in clinical practice report sleeping longer and more soundly within a few months.

The STEP 1 trial, published in the New England Journal of Medicine, found average weight reductions of around 15% over 68 weeks in adults using the 2.4mg maintenance dose alongside lifestyle changes. Weight loss of that magnitude commonly brings improvements in blood pressure, breathing at night, and energy levels throughout the day, all of which affect the quality of sleep. If you are curious about the broader picture, our page on whether Wegovy helps you sleep explores this in more depth, including what the evidence says about timing and who tends to benefit most.

There is a useful overview of the medicine's broader effects on the Wegovy treatment page, including how the dose schedule works and what to expect at each stage. Whether sleep improvement comes early or gradually tends to depend on how much of your sleep difficulty was driven by weight in the first place.

Can Wegovy cause sleep problems, at least at the start?

Yes, and it is worth being honest about this. Fatigue is a listed side effect in Wegovy's prescribing information, and some people feel unusually tired in the first few weeks, particularly after starting or after each dose increase. That tiredness is partly the body adjusting to a new appetite signal and partly the consequence of eating less; if your calorie intake drops sharply, energy dips can follow.

Nausea is the most common side effect overall, and if it arrives in the evening it can make getting off to sleep uncomfortable. A few people report vivid or unusual dreams, though this is not a widely documented pattern in the clinical literature. The NHS medicines page for semaglutide lists the full side-effect profile; gastrointestinal effects (nausea, indigestion, burping) are at the top of that list and are generally most noticeable in the early weeks.

Practical things that help: taking your weekly injection earlier in the day if evening nausea is a problem, eating smaller portions at dinner, and keeping well hydrated. If side effects feel unmanageable, the right conversation to have is with your prescriber, not a dose you adjust yourself. You can read more about how Wegovy may affect your sleep in a dedicated page that goes further into the mechanism.

What about feeling sleepy on Wegovy specifically?

Drowsiness is different from the fatigue described above. Some people feel genuinely sleepy in the hours after their injection, rather than just tired in a general sense. This tends to be mild and short-lived, and it often lessens as the body adapts over successive weeks.

The most practical advice is to time your injection for a day when a quieter afternoon is manageable, Saturday lunchtime before the weekly shop is easier to work around than a Monday morning before the commute. If sleepiness is significant enough to affect daily tasks or driving, that is something to flag with your prescriber rather than push through. There is a fuller look at this pattern on the sleepy on Wegovy page, including when it typically peaks and what usually helps.

It is also worth noting that disrupted sleep itself causes fatigue, creating a cycle that can be hard to unpick. If you are waking frequently (from sleep apnoea, anxiety about starting a new medicine, or simply from nausea) daytime tiredness is the predictable result. Addressing the cause matters more than managing the symptom.

Is the sleep-apnoea link backed by clinical evidence?

For Wegovy specifically, the most relevant evidence comes from the SELECT cardiovascular outcomes trial, which showed semaglutide significantly reduced the severity of obstructive sleep apnoea in adults with obesity, alongside its cardiovascular benefits. Novo Nordisk has since filed for regulatory approval of this indication in several markets; the UK picture for weight management remains the primary licensed use, but the sleep-apnoea data adds to the broader understanding of what semaglutide does beyond calorie reduction.

GLP-1 receptors are present in the brain as well as the gut, and researchers are still mapping exactly how semaglutide interacts with sleep architecture at a neurological level. It is an active area of study. For now, the clinical picture is that meaningful weight loss tends to improve sleep for people whose poor sleep was weight-related, while the medicine's early side effects may temporarily disrupt rest for some. Those two things are not contradictory; they often happen in sequence.

If you are weighing up treatment options and want to understand the cost picture alongside the clinical one, the Wegovy price comparison page sets out what UK private treatment typically includes and what to look for when comparing providers. And if you have a specific concern about how semaglutide may interact with something in your situation, our clinical team reviews every consultation personally before any prescription is issued. A common practical question that comes up at this stage is what to do if you forgot to take your Wegovy shot yesterday, and our dedicated page walks through exactly what the guidance says.